Jiaping He
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Mesenchymal stem cell research
Papers in
- Oncology 8
- CAR-T cell therapy research 8
-
- Osteoarthritis Treatment and Mechanisms 2
- Co-authors
- Xun Ye (3 shared papers)Wei William Cao (3 shared papers)Lianjun Shen (3 shared papers)Zhenguang Wang (2 shared papers)Meixia Chen (1 shared paper)Haoyi Wang (1 shared paper)Na Tang (1 shared paper)Jing Nie (1 shared paper)
- Journals
- Blood (2 papers)Blood Cancer Journal (2 papers)Clinical Cancer Research (1 paper)HemaSphere (1 paper)Tissue Engineering Part A (1 paper)
- Partner nations
- China
In The Last Decade
Jiaping He
15 papers receiving 627 citations
Peers
Comparison fields: 5 of 38
- Oncology 425
- Genetics 57
- Rheumatology 82
- Hematology 32
- Immunology 31
Countries citing papers authored by Jiaping He
This map shows the geographic impact of Jiaping He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaping He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaping He more than expected).
Fields of papers citing papers by Jiaping He
This network shows the impact of papers produced by Jiaping He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaping He. The network helps show where Jiaping He may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiaping He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 214 | |
| 2 | 2020 | 92 | |
| 3 | 2022 | 85 | |
| 4 | 2017 | 62 | |
| 5 | 2015 | 50 | |
| 6 | 2020 | 43 | |
| 7 | 2022 | 34 | |
| 8 | 2023 | 26 | |
| 9 | 2020 | 15 | |
| 10 | 2020 | 8 | |
| 11 | 2023 | 6 | |
| 12 | 2019 | 3 | |
| 13 | 2020 | 3 | |
| 14 | [Establishment of the methodology for quantifying lentiviral vector transcriptional read-through rate]. | 2013 | 2 |
| 15 | 2016 | 1 |
About Jiaping He
Jiaping He is a scholar working on Oncology, Rheumatology, Genetics, Hematology and Surgery, having authored 15 papers that have together received 644 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Pancreatitis Pathology and Treatment (2 papers), Virus-based gene therapy research (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers), RNA and protein synthesis mechanisms (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Animal Genetics and Reproduction (1 paper) and Multiple Myeloma Research and Treatments (1 paper). The work is most often cited by research in Oncology (425 citations), Genetics (57 citations), Rheumatology (82 citations), Hematology (32 citations) and Immunology (31 citations). Jiaping He has collaborated with scholars based in China. Frequent co-authors include Xun Ye, Wei William Cao, Lianjun Shen, Zhenguang Wang, Meixia Chen, Haoyi Wang, Na Tang, Jing Nie, Yang Liu and Qingming Yang. Their work appears in journals such as Blood, Blood Cancer Journal, Clinical Cancer Research, HemaSphere and Tissue Engineering Part A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.